Adherence in neurogeriatric patients

• Conditions: Focused on main diagnosis/disorders: cerebrovascular diseases, movement disorders, epilepsy, neuromuscular disorders, peripheral neurological disorders.; G70; G20; G72; G21; G23; G63; G81; G35; G37

• Registration Number: DRKS00016774
• Lead Sponsor: niversitätsklinikum Jena

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-02-19
• Study Completion: 2021-03-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 910

Inclusion Criteria

Patients over 60 years with a neurological disease

Exclusion Criteria

severe dementia, psychosis, delirium, inability to complete questionnaires

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is non-adherence in neurogeriatric patients derived from the Stendal Adherence with Medication Score (SAMS). Also disease-specific predictors of non-adherence, taking into account personal, environmental and procedural factors will be determined.

Secondary Outcome Measures

Name	Time	Method
Outcome follow-up surveys non-adherence, mortality and health-related quality of life in neurogeriatric patients at 12 months.